A group of French myeloma specialists recently published a review of treatment strategies for multiple myeloma patients who have relapsed or become resistant to previous therapies.

This Beacon article, the second in a two-part series, summarizes the review’s insights into issues that need to be considered when choosing among relapse treatment options

Part 1 summarizes the review’s perspectives on the use of novel agents in the treatment of relapsed and refractory myeloma.  

According to the authors of the review, the goal at relapse is to select a treatment regimen that maximizes …

A group of French myeloma specialists recently published a review of treatment strategies for multiple myeloma patients who have relapsed or become resistant to previous therapies.

This Beacon article, the first in a two-part series, summarizes the review's perspectives on the use of novel agents in the treatment of relapsed and refractory myeloma.  

A second Beacon article will look at the review's insights into issues that need to be considered when choosing among relapse treatment options.

The authors of the recent review begin their discussion by noting how use of the …